KARETAZAN
UNII B1QGD028V0

Substance Identification & Data

This profile provides standardized clinical and technical data for Karetazan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B1QGD028V0.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 81051-65-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
B1QGD028V0
CAS Registry Number
81051-65-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
KARETAZAN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C15H14ClNO3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
GQFJDWYHPRLNHR-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1(n(c(-c2ccc(cc2)Cl)c(c(c1)=O)C(=O)O)CC)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Karetazan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

KARETAZAN
KARETAZAN [ISO]

Systematic Nomenclature

2-(4-CHLOROPHENYL)-1-ETHYL-1,4-DIHYDRO-6-METHYL-4-OXO-3-PYRIDINECARBOXYLIC ACID
2-(4-CHLOROPHENYL)-1-ETHYL-1,4-DIHYDRO-6-METHYL-4-OXONICOTINIC ACID